Publications

Journal Article Review Epublish 1 citation

PubMed: 40488318 DOI: 10.1017/erm.2025.10007

Chemically modified non-coding RNAs in cancer.

Expert Rev Mol Med 27:e19

Authors: Lulu Yang, Boyang Wang, Zhaohui Gong

Affiliations

  • Department of Biochemistry and Molecular Biology and Zhejiang Key Laboratory of Pathophysiology, School of Basic Medical Sciences, Health Science Center, https://ror.org/03et85d35Ningbo University, Ningbo, Zhejiang, China.
  • Department of Biochemistry and Molecular Biology and Zhejiang Key Laboratory of Pathophysiology, School of Basic Medical Sciences, Health Science Center, https://ror.org/03et85d35Ningbo University, Ningbo, Zhejiang, China. Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.

Abstract

BACKGROUND

Non-coding RNAs (ncRNAs) are transcribed RNA molecules that do not encode proteins but regulate diverse biological processes. Dysregulation of ncRNAs is implicated in cancer, where chemical modifications such as N6-methyladenosine (m6A), N4-acetylcytidine (ac4C), and glycosylation critically influence their function. However, these modifications, as precise regulators of ncRNA activity, have been less well-documented and understood in tumorigenesis and cancer progression.

METHODS

This article systematically analyzes the roles of chemically modified ncRNAs - ribosomal RNA (rRNA), circular RNA (circRNA) and others - in cancer biology, synthesizingevidence from published studies on their mechanistic involvement in malignancy.

RESULTS

We reveal how specific chemical modifications drive oncogenesis, impact cancer diagnosis, and affect therapeutic responses, while also exploring their prognostic potential. Furthermore, we highlight emerging connections between ncRNA epitranscriptomics and cancer.

CONCLUSIONS

This review provides novel insights into ncRNA epitranscriptomics as emerging biomarkers and intervention targets for precision oncology.

MeSH

Molecular Biology, Neoplasms, Rna, Circular, Carcinogenesis, Diagnosis, Therapeutics, Epitranscriptomics